Plan your participation in the ESMO Targeted Anticancer Therapies Congress 2025, taking place in Paris, France, on 3-5 March 2025.
ESMO TAT is a key multi-stakeholder forum that brings together researchers, industry partners, investors, and regulatory bodies under the same roof, making the event essential for any professional involved in the development of new anticancer drugs.
Following last year's success, ESMO TAT 2025 will host again five Special Sessions with Industry, addressing drug development, methodological, regulatory, strategic financing, and investment issues, offering attendees wide-ranging perspective in areas not previously covered, including the development of innovative cancer therapeutics and their optimal implementation.
Empowering the expression of views of stakeholders beyond academia will enrich the educational and scientific content of ESMO TAT 2025 in the fascinating arena of therapeutic innovation.
How can I participate at ESMO TAT 2025?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.
For sponsorship information and a prospectus please contact:
Jon Roberts
Head of Strategic Partnerships
jon.roberts@esmo.org
Anna MacDougall
Strategic Partnerships Manager
anna.macdougall@esmo.org